Blog Category

Press Releases

Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia

,

/

11 September 2025

Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity

,

/

3 September 2025

SEPTEMBER 1st, 2025

,

/

1 September 2025

Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial

,

/

28 August 2025

Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million

,

/

5 August 2025

Biophytis Joins Silver Innov’, an Incubator Dedicated to the Silver Economy

,

/

30 July 2025

Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for Sarcopenia

,

/

15 July 2025

Biophytis Reports 2024 Financial Results and 2025 Outlook

,

/

11 July 2025

Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025

,

/

8 July 2025

Obesity: Biophytis Charts Its Course Toward a Booming Market

,

/

7 July 2025

Information on the Annual Financial Statements

,

/

30 June 2025

Biophytis announces the temporary suspension of the trading of its shares

,

/

19 June 2025